ACS Publications. Most Trusted. Most Cited. Most Read
Mechanistic Insights into Paracetamol Crystallization: Exploring Ultrasound and Hydrodynamic Cavitation with Quartz Crystal Microbalance Dissipation
My Activity
  • Open Access
Article

Mechanistic Insights into Paracetamol Crystallization: Exploring Ultrasound and Hydrodynamic Cavitation with Quartz Crystal Microbalance Dissipation
Click to copy article linkArticle link copied!

  • Madhumitha Dhanasekaran*
    Madhumitha Dhanasekaran
    Clean Energy Research Platform, Physical Sciences and Engineering (PSE) Division, King Abdullah University of Science and Technology (KAUST), Thuwal 23955-6900, Saudi Arabia
    *Email: [email protected]
  • Varaha P. Sarvothaman*
    Varaha P. Sarvothaman
    Clean Energy Research Platform, Physical Sciences and Engineering (PSE) Division, King Abdullah University of Science and Technology (KAUST), Thuwal 23955-6900, Saudi Arabia
    *Email: [email protected]
  • Paolo Guida
    Paolo Guida
    Clean Energy Research Platform, Physical Sciences and Engineering (PSE) Division, King Abdullah University of Science and Technology (KAUST), Thuwal 23955-6900, Saudi Arabia
    More by Paolo Guida
  • William L. Roberts
    William L. Roberts
    Clean Energy Research Platform, Physical Sciences and Engineering (PSE) Division, King Abdullah University of Science and Technology (KAUST), Thuwal 23955-6900, Saudi Arabia
Open PDF

ACS Engineering Au

Cite this: ACS Eng. Au 2024, XXXX, XXX, XXX-XXX
Click to copy citationCitation copied!
https://doi.org/10.1021/acsengineeringau.4c00036
Published December 4, 2024

© 2024 The Authors. Published by American Chemical Society. This publication is licensed under

CC-BY-NC-ND 4.0 .

Abstract

Click to copy section linkSection link copied!

Crystallization is a crucial process in the purification of active pharmaceutical ingredients (APIs). Achieving controlled and efficient crystal formation is vital in successful production for industrial applications. This study investigates the crystallization of paracetamol using a model system, focusing on two techniques: ultrasound cavitation (UC) and hydrodynamic cavitation (HC). The role of cavitation in enhancing crystallization is well-established by using ultrasound. However, the crystallization process utilizing HC, especially in the absence of an antisolvent, is not investigated. A detailed investigation is still necessary to understand the nucleation process at the molecular level. This work primarily focuses on forming paracetamol crystals in an aqueous medium without the need for an antisolvent in HC. To address the nucleation study at the molecular level, the quartz crystal microbalance with dissipation (QCM-D) technique was employed to explore the nucleation kinetics of paracetamol crystallization while the solution is cooling. QCM-D allowed for real-time monitoring of mass changes and viscoelastic properties on the sensor surface, providing valuable insights into the adsorption, growth, and dissolution kinetics of paracetamol crystals under the influence of both cavitation techniques. The study revealed distinct crystallization behaviors depending on the type and intensity of cavitation, shedding light on the underlying mechanisms and potential implications for pharmaceutical manufacturing and formulation. These findings indicate that high-quality crystals can be produced using HC without the need for an antisolvent. This work highlights the significant potential for improving the efficiency and control of paracetamol crystallization and plays an important role in scaling up the crystallization process using HC.

This publication is licensed under

CC-BY-NC-ND 4.0 .
  • cc licence
  • by licence
  • nc licence
  • nd licence
© 2024 The Authors. Published by American Chemical Society

1. Introduction

Click to copy section linkSection link copied!

Crystallization is the process of formation of solid crystals from a homogeneous liquid phase. (1) This process is an important separation and purification process in chemical and pharmaceutical industries. (2,3) For the pharmaceutical industry, crystallization plays a crucial role in the manufacturing of solid oral dosage forms as the properties of the final product, such as tablets, are heavily influenced by the crystal characteristics of the active pharmaceutical ingredient (API). This process enables the selective production of a highly pure API, while also allowing for precise control over crystal size and morphology, which is essential for creating engineered products. Managing these crystal attributes is critical for subsequent processes including isolation, drying, and packaging. Additionally, controlling crystal properties impacts batch stability, shelf life, tableting, and ultimately the bioavailability and dissolution of the API in the body. As a result, there is growing interest in engineering the crystal habit of pharmaceutical compounds to optimize their shape, size, and surface area for improved bioavailability. (4)
The supersaturation of the solute is the driving force for crystal formation, and this can be achieved in different ways. The commercial methods used to achieve supersaturation is by variation of temperature or by the addition of an antisolvent. (5) As long as operating conditions like temperature, concentration, and pressure promote crystallization, this process continually occurs. Despite significant advancements in nucleation theories in recent years, the templating or specific ordering within the solid state during the nucleation process remains not fully understood. (6)
Solvent, temperature, and crystallization conditions have a major impact on the formation of a different form of the drug. Particular forms of a drug have different physicochemical properties, which have an important influence on how it is processed into a drug product. (7) There are three polymorphic forms of paracetamol; the common crystal form (form I, monoclinic), which is used in the pharmaceutical product, is thermodynamically stable, whereas forms II and III are metastable phases, which can undergo solid phase transitions. Form I is prepared in large quantities and described as plate-shaped. The tablets produced by form I have high capping tendency because of the stiff construction of the molecules inside the crystal. (8,9)
Table 1 shows some of the literature studies of the paracetamol crystallization methods and the techniques to monitor the nucleation point in the crystal. This importance is due to its significant advantages in facilitating process design and operation. Consequently, key phenomena in cooling crystallization, such as crystal nucleation, growth, and the metastable zone width, have been extensively studied. These phenomena play a key role in crystal size, distribution, habits, purity, and polymorphs. During the crystal formation, the rate of crystal growth depends on the rate at which crystal units arrive at the crystal surface, which is influenced by the intensity of local convection near the crystal. (1,11)
Table 1. Studies Using a Paracetamol Crystallization System
#crystallization Processtechnique usednucleation identification methodreference
1cooling crystallizationultrasound cavitationvisual observationenergy efficient crystallization of paracetamol using pulsed ultrasound (17)
2antisolvent crystallizationultrasound cavitationsonoluminescenceultrasound-assisted crystallization of paracetamol: crystal size distribution and polymorph control (15)
3cooling crystallizationultrasound cavitationvisually at saturation temperaturedetermination of the effect of the ultrasonic frequency on the cooling crystallization of paracetamol (20)
4suspension crystallizationultrasound cavitationvisual observation/precipitationthe effect of ultrasound on the crystallization of paracetamol in the presence of structurally similar impurities (16)
5antisolvent crystallizationmagnetic stirrervisual observation/precipitationan approach to engineer paracetamol crystals by antisolvent crystallization technique in the presence of various additives for direct compression (21)
6crystallization in supercooled liquidterahertz time domain spectroscopyphase change observation in spectracrystallization and phase changes in paracetamol from the amorphous solid to the liquid phase (22)
7cooling crystallizationconventional coolingFouriertransform - near infrared spectroscopy - change in spectrapolymorph transformation in paracetamol monitored by in-line NIR spectroscopy during a cooling crystallization process (23)
8antisolvent crystallizationhydrodynamic cavitationno information about nucleationantisolvent crystallization: particle size distribution with different devices (24)
9oscillatory flow mixingoscillatory baffled batch crystallizerin situ atomic force microscopy and optical microscopycrystallization of paracetamol under oscillatory flow mixing conditions (25)
10cooling crystallization with additivesconventional coolingno information about nucleationtailoring crystal size distributions for product performance, compaction of paracetamol (26)
Ultrasound is proven to influence the crystallization system in several ways, such as (1) reduced induction time, (2) reduced amount of antisolvent, (3) limiting the crystal size distribution, and (4) effects in polymorphism. (12) Using the cavitation phenomenon, ultrasound establishes its physical effects throughout the crystallization process. (13) Cavitational collapse induces shockwaves, high temperature and pressure, microjets, and improved mixing. (14) It is well established that the influence of ultrasound enhances the crystallization process. For example, Kaur Bhangu et al. and Nyugen et al. studied the antisolvent crystallization using ultrasound and the effect of ultrasound on paracetamol crystals, respectively. Their results suggest that the variations in the ultrasound conditions significantly show changes in the crystal size and induction time. (15,16) Also, Gielen et al. monitored the energy efficiency of paracetamol crystallization using pulsed ultrasound and found that the final particle size of paracetamol crystals is controlled in the batch setup without affecting the crystal shape. (17) Ultrasound-assisted crystallization is typically conducted in batch processes. However, to scale up crystallization for industrial applications, the hydrodynamic cavitation (HC) method is preferable to facilitate crystallization on a larger scale. (10)
This study explores the use of HC to enhance crystal formation without the need for an antisolvent, aiming for industrial applicability. Cavitational collapse in HC is similar to that of ultrasound cavitation (UC), initiating crystal formation. In HC, high-pressure fluid flows through a constriction (e.g., an orifice or venturi), leading to a local drop in the pressure. When the pressure drops below the vapor pressure of the solvent (water), microbubbles form (nucleation), which induces supersaturation of the solution, which upon cooling forms crystals. While both UC and HC have been investigated separately for crystallization processes in a study, they have not yet been applied simultaneously to a single protein or drug using the cooling crystallization technique without an antisolvent. Furthermore, the properties of crystals prepared by the HC technique for industrial applications remain underexplored and require further research. In this study, paracetamol has been crystallized using a cooling crystallization technique by employing UC and HC to enhance the crystal formation. Paracetamol (or acetaminophen) is specifically chosen due to its ease in availability, and it is the common drug widely used as over the counter analgesic and antipyretic. Paracetamol is known to have three polymorphs: stable form I (monoclinic), metastable form II (orthorhombic), and unstable form III. (18,19) One of the major issues in pharmaceutical crystallization processes is relatively poor reproducibility, which in this study was overcome using the UC and HC cavitation systems.
Even though crystallization studies have evolved over generations, the study of nucleation is still under investigation and is not completely understood. Understanding nucleation is crucial for optimizing crystallization processes in various industrial applications including pharmaceuticals, chemicals, and materials science. Control over nucleation can lead to better product quality, improved yield, and more efficient manufacturing processes. This paper addresses the nucleation induction time during the cooling process in UC- and HC-influenced paracetamol crystals to understand the nucleation kinetics in paracetamol crystals using the quartz crystal microbalance with dissipation (QCM-D) technique.
The QCM-D technique is a sensitive tool that employs the piezoelectric properties of quartz crystals to measure the attached mass on the electrode surface. QCM-D provides a real-time, label-free detection for molecular interactions and structural changes at surfaces, which makes it unique for nucleation studies. The molecular interactions at the surfaces can be studied in detail during the process of cooling, which is lacking in other methods. Also, this method has attracted significant attention due to its simple concept, low cost, easy portability, high sensitivity, and diverse applications in various fields.
QCM-D analyzes the change in frequency and dissipation from which the kinetics of change in mass with time is monitored. The minor change in mass allowed us to precisely mark the nucleation point at the molecular level. A change in the resonant frequency can be related to a change in the mass according to the Sauerbrey equation. (27) QCM-D can measure resonance at multiple overtones and track dissipation (or complex frequency) shifts, allowing it to assess the viscoelastic properties of deposited materials such as storage and loss moduli. This capability extends QCM beyond its traditional role as a simple gravimetric tool, enabling more comprehensive material analysis. The QCM-D technique has been employed in a wide range of research topics, for example, self-assembled monolayers, viscoelastic polymers, and adsorption of biological macromolecules (proteins and DNA) and is also employed in electrochemical reactions. (28−32) Due to the adaptability, consistency, and sensitivity for in situ sensing of small differences in the working environment around a quartz crystal sensor, this technique is used in a wide range of studies.
In this study, we use the QCM-D technique, known for its high sensitivity to mass variations (1.07 ng/Hz), to accurately analyze crystal nuclei formation at the molecular level in paracetamol crystallization. (33) Following UC and HC treatments, paracetamol solution were cooled at 1 °C/min to initiate crystallization, during which QCM-D responses were recorded to track both resonant frequency and dissipation. This enables us to calculate changes in the adsorbed mass on the sensor surface and pinpoint the nucleation induction point of the crystal. Our goal is to utilize QCM-D, to determine this nucleation point with precision, facilitated by UC and HC crystals. The findings from this study could aid in developing real-time monitoring systems for crystal formation and have potential applications across various crystallization methods.

2. Materials, Reactors, and Analytical Techniques Employed

Click to copy section linkSection link copied!

2.1. Materials

Paracetamol (Acetaminophen) was obtained from Apollo Scientific and used without further purification. 20 g L–1 solution of paracetamol was prepared in water (Milli-Q, resistance 18.2 MΩcm). The solution was heated to 80 °C under stirring while avoiding any evaporation to dissolve the solute completely. To confirm the solute dissolution, the solution was filtered over a 0.45 mm Millipore HAWP filter to remove any impurities, before transferring it to the experimental setup.

2.2. Reactors Employed in the Study

2.2.1. Ultrasound Cavitation

The Hielscher UP400 St operating at a frequency of 24 kHz was used to introduce ultrasound into the solution containing paracetamol, the amplitude was set at 24.5 μm (100%), and the duty cycle was set at 1.0 (continuous mode of operation). The treatment consisted of 20 min of ultrasound application, the initial temperature of this operation was 18 °C, which was increased to 70 °C at the end of the treatment. After the application of ultrasound, the solution was left for cooling at a rate of 1 °C/min, and the temperature was monitored. The crystals were formed by this cooling process, and the formed crystals were filtered using a vacuum filtration technique and allowed to dry for a period of 2 h at 80 °C. The formed crystals were used further for characterization.

2.2.2. Hydrodynamic Cavitation

A vortex-diode based cavitation device (dt = 3 mm, nominal flow rate of 1 LPM) was procured from VIVIRA Process Technologies, India. In a vortex-diode based cavitation device, the phenomenon of cavitation is set up in its flow path. The fluid enters tangentially, creating a rotational flow that forms a free vortex. The free vortex induces a pressure drop as the liquid swirls within the vortex chamber. When the local pressure at the center of the vortex is less than the vapor pressure of liquid, cavities form and collapse, leading to cavitation (the geometry of this device is presented in Figure 1). An experimental setup similar to previous HC-based studies (34,35) was designed and operated. The HC loop employed a Grundfos PKm60 pump, and the frequency of the pump was manipulated by the use of a variable frequency drive. Other pipe fittings, such as ball valves and pressure gauges, were procured locally from Jeddah City, Saudi Arabia. The schematic of the HC reactor is presented in Figure 1. The operating pressure was chosen as ΔP = 200-kPag based on previous work. (36) The HC operation was performed for a duration of 10 min with temperature of this operation initially being 18 °C and increasing to 50 °C at the end of the treatment; no heat exchangers were used and the operation was a nonisothermal one.

Figure 1

Figure 1. Geometry of the vortex-based hydrodynamic reactor (Reproduced with permission from [37], Copyright [2019] [John Wiley and Sons], Simpson and Ranade (37)) and schematic of the experimental setup employed in this work.

The crystals obtained from both methods were weighed to determine the crystallization yield. The yield was calculated using the following formula
Yield(%)=(MassoftheCrystalsobtainedInitialmassofthesubstance)×100
(1)

2.3. Analytical Techniques

2.3.1. Scanning Electron Micrographs

Scanning electron microscopy (SEM) was performed by using a field emission scanning electron microscope (Nova Nano SEM 630). The paracetamol crystals were mounted to the SEM stub and then coated with an Iridium prior to SEM observation.

2.3.2. Powder X-ray Diffraction Analysis

Powder X-ray diffraction (XRD) was analyzed for paracetamol crystals using a Bruker D2 Phaser X-ray Diffractometer for phase identification and crystallinity at room temperature. The diffractometer used Cu Kα radiation (λ = 1.54 Å) at an acceleration voltage of 30 kV and a current of 15 mA. The samples were scanned from 5 to 40° of 2θ with a step size of 0.01°.

2.3.3. Differential Scanning Calorimetry

The relative stability of paracetamol was analyzed using differential scanning calorimetry (DSC) (DSC-250 TA Instruments) by measuring the temperature and heat flows associated with paracetamol crystals. Using standard crucibles, a quantity of about 3 mg of paracetamol was measured and added. The measurements were performed under an inert nitrogen atmosphere to prevent potential oxidation. The heating–cooling–heating test was carried out using the following temperature program: heating samples at a rate of 10 °C/min from 25 to 200 °C, isotherm for 10 min, cooling at a rate 50 °C/min from 250 to 25 °C, isotherm for 10 min, and the second heating at a rate 10 °C/min to 200 °C.

2.3.4. Quartz Crystal Microbalance with Dissipation

QCM-D measurements were performed with a Q-sense analyzer (QE401, Biolin Scientific) by using gold-coated crystal sensors. The QCM-D crystal sensors were cleaned using acetone and ethanol and blow-dried using nitrogen. Cleaned substrates were used for further studies. The QCM-D response of the bare sensors was monitored in air as a control experiment. Injecting fluid into the chamber at a constant flow rate of 100 μL/min results in significant changes in the QCM-D signals. The resonance frequency and bandwidths have been collected for overtones, n, between 3 and 11, corresponding to frequencies between 15 and 55 MHz. Following the conventional methodology, the change in mass (Δm) was calculated using the Sauerbrey equation, which relates the changes in mass to the frequency differences, using one overtone (n).
Δm=c.Δfn
(2)
where Δm is the change in mass, C mass sensitivity constant −17.7 ng/(cm2·Hz), Δf resonance frequency change, and n number of Harmonics.

3. Results and Discussion

Click to copy section linkSection link copied!

3.1. Crystallization Yield

During the crystallization process, after cavitation treatment (both in UC and HC methods), the solution is allowed to cool naturally, allowing time for crystal formation. The crystals were collected by filtration, dried, and weighed to calculate the yield using eq 1. Table 2 presents the yield details along with the initial mass and final mass obtained in the crystallization process. The yield was found to be 49.6% for crystals produced using the UC crystallization method and 72.5% for crystals produced using the HC crystallization method. The difference in yield percentage may be attributed to the varying volumes of liquid processed, as well as the differences in amplitude and frequency ranges utilized in the UC and HC methods. These crystals were further studied and characterized for purity.
Table 2. Paracetamol Crystal Yield Percentage Crystallized by UC and HC
initial mass of paracetamol (g)volume of liquid (mL)cavitation typemass of the crystal obtained (g)yield (%)
10500UC4.9649.6
452500HC7.2572.5

3.2. SEM Imaging

The SEM images of paracetamol crystals were taken. Figure 2a shows the crystals formed using UC, and Figure 2b shows the crystals formed by using HC. From these images, it is observed that the crystals formed using UC and HC have the consistent polymorph of the monoclinic I form. which is more stable. This agrees well with the reported crystal morphology. (4,38) The prismatic shape is maintained in both the experimental conditions; the only effect that is noticed in these two-preparation methods is the reduced particle size, which is clearly noticeable in SEM images. It can be observed that there are some small crystals that are visible and tend to stick to the larger crystals; these are produced due to the fragmentation process during the cavitation crystallization procedure. (39,40)

Figure 2

Figure 2. Paracetamol crystals induced by (a) UC-based processing and (b) HC-based processing.

3.3. Powder X-ray Diffraction

Powder XRD analysis was performed to monitor the polymorphs of the crystal formed using UC and HC methods. The paracetamol crystals obtained from the two different cavitation methods have similar XRD patterns, as shown in Figure 3a,b, thus confirming the formation of the form 1 monoclinic crystal. The presence of sharp peaks indicates that the paracetamol crystals produced using these two cavitation methods have high crystallinity and have a well-ordered internal structure, which is similar to the conventional method of crystal formation. The prominent peaks at specific 2θ values, typically around 13°, 15°, 20°, and 23°, proves that the crystals belong to the form I polymorph. (41)

Figure 3

Figure 3. XRD results for (a) UC- and (b) HC-based processing.

The UC-induced paracetamol crystals show significantly higher peak intensities than the HC sample. The higher intensities in the UC method are due to the larger or more uniformly oriented crystals; also, UC affects the nucleation and growth rates differently than HC. The difference in peak intensity between UC and HC suggests that the cavitation method influences certain aspects of crystal growth. Hence, the difference in relative intensities of the peaks is due to the different crystal preparation methods. In terms of peak position, the two XRD patterns agree well with those reported in the literature for paracetamol form I, confirming the crystal form and ensuring consistency with previously reported data. (42−44)

3.4. Differential Scanning Calorimetry

The DSC curves of paracetamol crystals produced using UC and HC are shown in Figure 4a,b, respectively. The DSC curves of paracetamol crystals prepared using UC and HC show a single endothermic peak at 170.9 and 171.4 °C, respectively, due to the melting of polymorphic form I (monoclinic), which is consistent with the literature. (45,46) The sharpness of the peak indicates a well-defined melting point, which is characteristic of a pure crystalline material. Also, the crystal produced using UC and HC does not significantly alter the crystalline structure of the paracetamol, which is also proven by powder XRD. Hence, UC and HC methods of producing paracetamol crystals provide a promising result by enhancing the growth rate compared to conventional methods of cooling crystallization, which will be very useful for industrial applications. (47)

Figure 4

Figure 4. DSC results for (a) UC- and (b) HC-based processing.

3.5. QCM-D Results

After the application of UC and HC to paracetamol solutions, QCM-D measurements were recorded during the cooling phase to observe the onset of nucleation. The changes in frequency (Δf) and dissipation (ΔD) were tracked to monitor the crystallization process of paracetamol. (33,48) Using the Sauerbrey equation, the change in mass (Δm) was calculated to assess the nucleation kinetics, providing insights into the rate of mass accumulation and the formation of a crystalline structure over time. The paracetamol solution (20 g/L) was maintained at a temperature of 50 °C, the cooling rate was set at 1 °C/min when QCM-D measurements began, and Δf and Δm were monitored. As the solution cooled, Δf changed due to the viscosity shift.
During further cooling, as the viscosity increased, the mass on the QCM-D sensor gradually accumulated. In the initial phase, both Δf and Δm exhibited fluctuations, suggesting dynamic nucleation events with rapid adsorption on the sensor surface. Over time, these fluctuations decreased as mass accumulation became steadier, indicating the progressive growth of the crystal layer on the sensor. In samples influenced by ultrasound (UC), mass accumulation began immediately at 100 s (Figure 5a), with nucleation intensifying after 400 s, leading to rapid crystal formation. In contrast, for HC samples (Figure 5b), mass increase was more gradual, with nucleation beginning around 700 s and continuing up to 6000 s, where it reached a saturation point. (17) This gradual buildup in HC suggests that a stable, highly crystalline layer formed on the sensor surface over time.

Figure 5

Figure 5. QCM-D results for (a) UC- and (b) HC-based processing.

The QCM-D results, based on induction time, indicate that even though the crystals formed by UC and HC have the same polymorph of form I, the nucleation starts at different time intervals, which is due to the power and cavitation intensities in UC and HC. Hence, it is important to note that the operating volumes and cavitational intensities of the two methods are different. The ultrasound setup had a smaller operating volume of 0.2 L (for QCM and 0.5 L for the yield calculation experiment), whereas HC used a 2.5 L volume. In the ultrasound system, cavitation is concentrated near the tip of the sonotrode, while in HC, it is distributed as the liquid exits the vortex reactor.
These presented results focused on comparing cavitation-induced crystallization in the absence of the antisolvent and evaluating the effectiveness of QCM-D for in situ monitoring of crystallization behavior. By analyzing the nucleation induction time and nucleation rates, further insights into the mechanical properties of the crystals, such as stiffness and damping, were gained. (49)

4. Conclusions

Click to copy section linkSection link copied!

The study conclusively demonstrates that both UC and HC significantly influence the crystallization dynamics of paracetamol with distinct effects on nucleation kinetics and crystal growth. Utilizing HC without the presence of an antisolvent provides a viable pathway for the crystallization process, facilitating the scalability for industrial applications. By employing the QCM-D technique, the research provides detailed, real-time insights into how different cavitational forces impact the adsorption, growth, and dissolution of paracetamol crystals. The findings highlight that the type and intensity of cavitation are critical factors in controlling the crystallization behavior, which can be leveraged to optimize pharmaceutical manufacturing processes. Ultimately, this study contributes to a deeper understanding of the cavitation phenomena, offering a pathway to enhance the efficiency and control of crystallization in the production of paracetamol and other crystalline compounds with potential applications in improving drug formulation and quality. Future studies could explore the use of multiple cavitation zones either through specialized sonotrode designs or by operating HC reactors with various other drugs. This approach demonstrates that the findings are not limited to paracetamol alone. Additionally, it could help accelerate cavitation-induced crystallization, facilitating scalability in pharmaceutical applications.

Author Information

Click to copy section linkSection link copied!

  • Corresponding Authors
  • Authors
    • Paolo Guida - Clean Energy Research Platform, Physical Sciences and Engineering (PSE) Division, King Abdullah University of Science and Technology (KAUST), Thuwal 23955-6900, Saudi ArabiaOrcidhttps://orcid.org/0000-0002-9805-9291
    • William L. Roberts - Clean Energy Research Platform, Physical Sciences and Engineering (PSE) Division, King Abdullah University of Science and Technology (KAUST), Thuwal 23955-6900, Saudi Arabia
  • Author Contributions

    CRediT: Madhumitha Dhanasekaran conceptualization, investigation, methodology, writing - original draft; Varaha Prasad Sarvothaman formal analysis, methodology, validation, writing - review & editing; Paolo Guida supervision, validation, writing - review & editing; William L. Roberts conceptualization, supervision.

  • Notes
    The authors declare no competing financial interest.

Acknowledgments

Click to copy section linkSection link copied!

The authors would like to gratefully thank Professor Sahika Inal, Bioengineering Biological and Environmental Science and Engineering Division, KAUST, and Dr. Jokubas Surgailis for the use of the QCM-D technique used in this work. The authors would also like to thank the KAUST Core Laboratories for enabling the use of other analytical techniques used in this work.

References

Click to copy section linkSection link copied!

This article references 49 other publications.

  1. 1
    Mullin, J. W. Crystallization; Elsevier, 2001.
  2. 2
    Kordylla, A.; Koch, S.; Tumakaka, F.; Schembecker, G. Towards an optimized crystallization with ultrasound: Effect of solvent properties and ultrasonic process parameters. J. Cryst. Growth 2008, 310 (18), 41774184,  DOI: 10.1016/j.jcrysgro.2008.06.057
  3. 3
    Luque de Castro, M. D.; Priego-Capote, F. Ultrasound-assisted crystallization (sonocrystallization). Ultrason. Sonochem. 2007, 14 (6), 717724,  DOI: 10.1016/j.ultsonch.2006.12.004
  4. 4
    Keshavarz, L.; Pishnamazi, M.; Rao Khandavilli, U. B.; Shirazian, S.; Collins, M. N.; Walker, G. M.; Frawley, P. J. Tailoring crystal size distributions for product performance, compaction of paracetamol. Arabian J. Chem. 2021, 14 (4), 103089,  DOI: 10.1016/j.arabjc.2021.103089
  5. 5
    Nalajala, V. S.; Moholkar, V. S. Investigations in the physical mechanism of sonocrystallization. Ultrason. Sonochem. 2011, 18 (1), 345355,  DOI: 10.1016/j.ultsonch.2010.06.016
  6. 6
    Oxtoby, D. W. Crystal nucleation in simple and complex fluids. Philos. Trans. R. Soc., A 2003, 361 (1804), 419428,  DOI: 10.1098/rsta.2002.1145
  7. 7
    Chadha, R.; Gupta, S.; Shukla, G. Crystal habit, characterization and pharmacological activity of various crystal forms of arteether. Acta Pharm. Sin. B 2011, 1 (2), 129135,  DOI: 10.1016/j.apsb.2011.06.010
  8. 8
    Krycer, I.; Pope, D. G.; Hersey, J. A. The prediction of paracetamol capping tendencies. J. Pharm. Pharmacol. 1982, 34 (12), 802804,  DOI: 10.1111/j.2042-7158.1982.tb06229.x
  9. 9
    Bauer, J.; Spanton, S.; Henry, R.; Quick, J.; Dziki, W.; Porter, W.; Morris, J. Ritonavir: an extraordinary example of conformational polymorphism. Pharm. Res. 2001, 18, 859866,  DOI: 10.1023/A:1011052932607
  10. 10
    Astier, J.-P.; Veesler, S. Using Temperature To Crystallize Proteins: A Mini-Review. Cryst. Growth Des. 2008, 8 (12), 42154219,  DOI: 10.1021/cg800665b
  11. 11
    Nývlt, J. Design of batch crystallizers. In Industrial Crystallization; Springer, 1976; pp 335342.
  12. 12
    McCausland, L. J.; Cains, P. W.; Martin, P. D. Use the power of sonocrystallization for improved properties. Chem. Eng. Prog. 2001, 97 (7), 5661
  13. 13
    Prasad, R.; Dalvi, S. V. Sonocrystallization: Monitoring and controlling crystallization using ultrasound. Chem. Eng. Sci. 2020, 226, 115911,  DOI: 10.1016/j.ces.2020.115911
  14. 14
    Leighton, T. The Acoustic Bubble; Academic Press, 2012.
  15. 15
    Kaur Bhangu, S.; Ashokkumar, M.; Lee, J. Ultrasound assisted crystallization of paracetamol: crystal size distribution and polymorph control. Cryst. Growth Des. 2016, 16 (4), 19341941,  DOI: 10.1021/acs.cgd.5b01470
  16. 16
    Nguyen, T. T. H.; Khan, A.; Bruce, L. M.; Forbes, C.; O’Leary, R. L.; Price, C. J. The effect of ultrasound on the crystallisation of paracetamol in the presence of structurally similar impurities. Crystals 2017, 7 (10), 294,  DOI: 10.3390/cryst7100294
  17. 17
    Gielen, B.; Kusters, P.; Jordens, J.; Thomassen, L. C. J.; Van Gerven, T.; Braeken, L. Energy efficient crystallization of paracetamol using pulsed ultrasound. Chem. Eng. Process. 2017, 114, 5566,  DOI: 10.1016/j.cep.2017.01.001
  18. 18
    Di Martino, P.; Conflant, P.; Drache, M.; Huvenne, J. P.; Guyot-Hermann, A. M. Preparation and physical characterization of forms II and III of paracetamol. J. Therm. Anal. Calorim. 1997, 48, 447458,  DOI: 10.1007/BF01979491
  19. 19
    Wang, I. C.; Lee, M. J.; Seo, D. Y.; Lee, H. E.; Choi, Y.; Kim, W. S.; Kim, C. S.; Jeong, M. Y.; Choi, G. J. Polymorph transformation in paracetamol monitored by in-line NIR spectroscopy during a cooling crystallization process. AAPS PharmSciTech 2011, 12 (2), 764770,  DOI: 10.1208/s12249-011-9642-x
  20. 20
    Jordens, J.; Gielen, B.; Braeken, L.; Van Gerven, T. Determination of the effect of the ultrasonic frequency on the cooling crystallization of paracetamol. Chem. Eng. Process. 2014, 84, 3844,  DOI: 10.1016/j.cep.2014.01.006
  21. 21
    Kaialy, W.; Larhrib, H.; Chikwanha, B.; Shojaee, S.; Nokhodchi, A. An approach to engineer paracetamol crystals by antisolvent crystallization technique in presence of various additives for direct compression. Int. J. Pharm. 2014, 464 (1–2), 5364,  DOI: 10.1016/j.ijpharm.2014.01.026
  22. 22
    Sibik, J.; Sargent, M. J.; Franklin, M.; Zeitler, J. A. Crystallization and phase changes in paracetamol from the amorphous solid to the liquid phase. Mol. Pharmaceutics 2014, 11 (4), 13261334,  DOI: 10.1021/mp400768m
  23. 23
    Wang, I.-C.; Lee, M.-J.; Seo, D.-Y.; Lee, H.-E.; Choi, Y.; Kim, W.-S.; Kim, C.-S.; Jeong, M.-Y.; Choi, G. J. Polymorph transformation in paracetamol monitored by in-line NIR spectroscopy during a cooling crystallization process. AAPS PharmSciTech 2011, 12, 764770,  DOI: 10.1208/s12249-011-9642-x
  24. 24
    Madane, K.; Ranade, V. V. Anti-solvent crystallization: Particle size distribution with different devices. Chem. Eng. J. 2022, 446, 137235,  DOI: 10.1016/j.cej.2022.137235
  25. 25
    Chew, C. M.; Ristic, R. I.; Dennehy, R. D.; De Yoreo, J. J. Crystallization of paracetamol under oscillatory flow mixing conditions. Cryst. Growth Des. 2004, 4 (5), 10451052,  DOI: 10.1021/cg049913l
  26. 26
    Keshavarz, L.; Pishnamazi, M.; Khandavilli, U. B. R.; Shirazian, S.; Collins, M. N.; Walker, G. M.; Frawley, P. J. Tailoring crystal size distributions for product performance, compaction of paracetamol. Arabian J. Chem. 2021, 14 (4), 103089,  DOI: 10.1016/j.arabjc.2021.103089
  27. 27
    Sauerbrey, G. Verwendung von Schwingquarzen zur Wägung dünner Schichten und zur Mikrowägung. Z. Phys. 1959, 155 (2), 206222,  DOI: 10.1007/BF01337937
  28. 28
    Janshoff, A.; Galla, H. J.; Steinem, C. Piezoelectric mass-sensing devices as biosensors-an alternative to optical biosensors?. Angew. Chem., Int. Ed. 2000, 39 (22), 40044032,  DOI: 10.1002/1521-3773(20001117)39:22<4004::AID-ANIE4004>3.0.CO;2-2
  29. 29
    Xiang, C.; Xie, Q.; Hu, J.; Yao, S. Studies on electrochemical copolymerization of aniline with o-phenylenediamine and degradation of the resultant copolymers via electrochemical quartz crystal microbalance and scanning electrochemical microscope. Synth. Met. 2006, 156 (5–6), 444453,  DOI: 10.1016/j.synthmet.2006.01.010
  30. 30
    Snook, G. A.; Chen, G. Z. The measurement of specific capacitances of conducting polymers using the quartz crystal microbalance. J. Electroanal. Chem. 2008, 612 (1), 140146,  DOI: 10.1016/j.jelechem.2007.08.024
  31. 31
    Madhumitha, D.; Dhathathreyan, A. Interaction of Myoglobin colloids with BSA in solution: Insights into complex formation and elastic compliance. Int. J. Biol. Macromol. 2017, 105, 12591268,  DOI: 10.1016/j.ijbiomac.2017.07.157
  32. 32
    Dhanasekaran, M.; Jaganathan, M.; Dhathathreyan, A. Colloids versus solution state adsorption of proteins: Interaction of Myoglobin with supported lipid bilayers. Int. J. Biol. Macromol. 2018, 114, 434440,  DOI: 10.1016/j.ijbiomac.2018.03.078
  33. 33
    Liu, L.-S.; Kim, J.-M.; Kim, W.-S. Quartz Crystal Microbalance Technique for in Situ Analysis of Supersaturation in Cooling Crystallization. Anal. Chem. 2016, 88 (11), 57185724,  DOI: 10.1021/acs.analchem.5b04609
  34. 34
    Sarvothaman, V. P.; Velisoju, V. K.; Subburaj, J.; Panithasan, M. S.; Kulkarni, S. R.; Castaño, P.; Turner, J.; Guida, P.; Roberts, W. L.; Nagarajan, S. Is cavitation a truly sensible choice for intensifying photocatalytic oxidation processes?–Implications on phenol degradation using ZnO photocatalysts. Ultrason. Sonochem. 2023, 99, 106548,  DOI: 10.1016/j.ultsonch.2023.106548
  35. 35
    Sarvothaman, V. P.; Simpson, A. T.; Ranade, V. V. Modelling of vortex based hydrodynamic cavitation reactors. Chem. Eng. J. 2019, 377, 119639,  DOI: 10.1016/j.cej.2018.08.025
  36. 36
    Ranade, V. V.; Prasad Sarvothaman, V.; Simpson, A.; Nagarajan, S. Scale-up of vortex based hydrodynamic cavitation devices: A case of degradation of di-chloro aniline in water. Ultrason. Sonochem. 2021, 70, 105295,  DOI: 10.1016/j.ultsonch.2020.105295
  37. 37
    Simpson, A.; Ranade, V. V. Flow characteristics of vortex based cavitation devices: Computational investigation on influence of operating parameters and scale. AIChE J. 2019, 65 (9), e16675  DOI: 10.1002/aic.16675
  38. 38
    Bučar, D.-K.; Elliott, J. A.; Eddleston, M. D.; Cockcroft, J. K.; Jones, W. Sonocrystallization Yields Monoclinic Paracetamol with Significantly Improved Compaction Behavior. Angew. Chem., Int. Ed. 2015, 54 (1), 249253,  DOI: 10.1002/anie.201408894
  39. 39
    Kim, H. N.; Suslick, K. S. The Effects of Ultrasound on Crystals: Sonocrystallization and Sonofragmentation. Crystals 2018, 8 (7), 280,  DOI: 10.3390/cryst8070280
  40. 40
    Gielen, B.; Claes, T.; Janssens, J.; Jordens, J.; Thomassen, L. C. J.; Gerven, T. V.; Braeken, L. Particle Size Control during Ultrasonic Cooling Crystallization of Paracetamol. Chem. Eng. Technol. 2017, 40, 13001308,  DOI: 10.1002/ceat.201600647
  41. 41
    Kachrimanis, K.; Braun, D. E.; Griesser, U. J. Quantitative analysis of paracetamol polymorphs in powder mixtures by FT-Raman spectroscopy and PLS regression. J. Pharm. Biomed. Anal. 2007, 43 (2), 407412,  DOI: 10.1016/j.jpba.2006.07.032
  42. 42
    Yamamura, S.; Momose, Y. Characterization of monoclinic crystals in tablets by pattern-fitting procedure using X-ray powder diffraction data. Int. J. Pharm. 2003, 259 (1), 2737,  DOI: 10.1016/S0378-5173(03)00206-0
  43. 43
    Shtukenberg, A. G.; Tan, M.; Vogt-Maranto, L.; Chan, E. J.; Xu, W.; Yang, J.; Tuckerman, M. E.; Hu, C. T.; Kahr, B. Melt Crystallization for Paracetamol Polymorphism. Cryst. Growth Des. 2019, 19 (7), 40704080,  DOI: 10.1021/acs.cgd.9b00473
  44. 44
    Oloyede, O. O.; Alabi, Z. O.; Akinyemi, A. O.; Oyelere, S. F.; Oluseye, A. B.; Owoyemi, B. C. D. Comparative evaluation of acetaminophen form (I) in commercialized paracetamol brands. Sci. Afr. 2023, 19, e01537  DOI: 10.1016/j.sciaf.2022.e01537
  45. 45
    Giordano, F.; Rossi, A.; Bettini, R.; Savioli, A.; Gazzaniga, A.; Novák, C. S. Thermal behavior of paracetamol-polymeric excipients mixtures. J. Therm. Anal. Calorim. 2002, 68 (2), 575590,  DOI: 10.1023/A:1016004206043
  46. 46
    Klímová, K.; Leitner, J. DSC study and phase diagrams calculation of binary systems of paracetamol. Thermochim. Acta 2012, 550, 5964,  DOI: 10.1016/j.tca.2012.09.024
  47. 47
    Sacchetti, M. Thermodynamic Analysis of DSC Data for Acetaminophen Polymorphs. J. Therm. Anal. Calorim. 2001, 63, 345350,  DOI: 10.1023/A:1010180123331
  48. 48
    Liu, L.-S.; Kim, J.-M.; Chang, S.-M.; Choi, G.-J.; Kim, W.-S. Quartz Crystal Microbalance Technique for Analysis of Cooling Crystallization. Anal. Chem. 2013, 85, 47904796,  DOI: 10.1021/ac400585c
  49. 49
    Lapidot, T.; Sedransk Campbell, K. L.; Heng, J. Y. Y. Model for Interpreting Surface Crystallization Using Quartz Crystal Microbalance: Theory and Experiments. Anal. Chem. 2016, 88 (9), 48864893,  DOI: 10.1021/acs.analchem.6b00713

Cited By

Click to copy section linkSection link copied!

This article has not yet been cited by other publications.

ACS Engineering Au

Cite this: ACS Eng. Au 2024, XXXX, XXX, XXX-XXX
Click to copy citationCitation copied!
https://doi.org/10.1021/acsengineeringau.4c00036
Published December 4, 2024

© 2024 The Authors. Published by American Chemical Society. This publication is licensed under

CC-BY-NC-ND 4.0 .

Article Views

245

Altmetric

-

Citations

-
Learn about these metrics

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.

  • Abstract

    Figure 1

    Figure 1. Geometry of the vortex-based hydrodynamic reactor (Reproduced with permission from [37], Copyright [2019] [John Wiley and Sons], Simpson and Ranade (37)) and schematic of the experimental setup employed in this work.

    Figure 2

    Figure 2. Paracetamol crystals induced by (a) UC-based processing and (b) HC-based processing.

    Figure 3

    Figure 3. XRD results for (a) UC- and (b) HC-based processing.

    Figure 4

    Figure 4. DSC results for (a) UC- and (b) HC-based processing.

    Figure 5

    Figure 5. QCM-D results for (a) UC- and (b) HC-based processing.

  • References


    This article references 49 other publications.

    1. 1
      Mullin, J. W. Crystallization; Elsevier, 2001.
    2. 2
      Kordylla, A.; Koch, S.; Tumakaka, F.; Schembecker, G. Towards an optimized crystallization with ultrasound: Effect of solvent properties and ultrasonic process parameters. J. Cryst. Growth 2008, 310 (18), 41774184,  DOI: 10.1016/j.jcrysgro.2008.06.057
    3. 3
      Luque de Castro, M. D.; Priego-Capote, F. Ultrasound-assisted crystallization (sonocrystallization). Ultrason. Sonochem. 2007, 14 (6), 717724,  DOI: 10.1016/j.ultsonch.2006.12.004
    4. 4
      Keshavarz, L.; Pishnamazi, M.; Rao Khandavilli, U. B.; Shirazian, S.; Collins, M. N.; Walker, G. M.; Frawley, P. J. Tailoring crystal size distributions for product performance, compaction of paracetamol. Arabian J. Chem. 2021, 14 (4), 103089,  DOI: 10.1016/j.arabjc.2021.103089
    5. 5
      Nalajala, V. S.; Moholkar, V. S. Investigations in the physical mechanism of sonocrystallization. Ultrason. Sonochem. 2011, 18 (1), 345355,  DOI: 10.1016/j.ultsonch.2010.06.016
    6. 6
      Oxtoby, D. W. Crystal nucleation in simple and complex fluids. Philos. Trans. R. Soc., A 2003, 361 (1804), 419428,  DOI: 10.1098/rsta.2002.1145
    7. 7
      Chadha, R.; Gupta, S.; Shukla, G. Crystal habit, characterization and pharmacological activity of various crystal forms of arteether. Acta Pharm. Sin. B 2011, 1 (2), 129135,  DOI: 10.1016/j.apsb.2011.06.010
    8. 8
      Krycer, I.; Pope, D. G.; Hersey, J. A. The prediction of paracetamol capping tendencies. J. Pharm. Pharmacol. 1982, 34 (12), 802804,  DOI: 10.1111/j.2042-7158.1982.tb06229.x
    9. 9
      Bauer, J.; Spanton, S.; Henry, R.; Quick, J.; Dziki, W.; Porter, W.; Morris, J. Ritonavir: an extraordinary example of conformational polymorphism. Pharm. Res. 2001, 18, 859866,  DOI: 10.1023/A:1011052932607
    10. 10
      Astier, J.-P.; Veesler, S. Using Temperature To Crystallize Proteins: A Mini-Review. Cryst. Growth Des. 2008, 8 (12), 42154219,  DOI: 10.1021/cg800665b
    11. 11
      Nývlt, J. Design of batch crystallizers. In Industrial Crystallization; Springer, 1976; pp 335342.
    12. 12
      McCausland, L. J.; Cains, P. W.; Martin, P. D. Use the power of sonocrystallization for improved properties. Chem. Eng. Prog. 2001, 97 (7), 5661
    13. 13
      Prasad, R.; Dalvi, S. V. Sonocrystallization: Monitoring and controlling crystallization using ultrasound. Chem. Eng. Sci. 2020, 226, 115911,  DOI: 10.1016/j.ces.2020.115911
    14. 14
      Leighton, T. The Acoustic Bubble; Academic Press, 2012.
    15. 15
      Kaur Bhangu, S.; Ashokkumar, M.; Lee, J. Ultrasound assisted crystallization of paracetamol: crystal size distribution and polymorph control. Cryst. Growth Des. 2016, 16 (4), 19341941,  DOI: 10.1021/acs.cgd.5b01470
    16. 16
      Nguyen, T. T. H.; Khan, A.; Bruce, L. M.; Forbes, C.; O’Leary, R. L.; Price, C. J. The effect of ultrasound on the crystallisation of paracetamol in the presence of structurally similar impurities. Crystals 2017, 7 (10), 294,  DOI: 10.3390/cryst7100294
    17. 17
      Gielen, B.; Kusters, P.; Jordens, J.; Thomassen, L. C. J.; Van Gerven, T.; Braeken, L. Energy efficient crystallization of paracetamol using pulsed ultrasound. Chem. Eng. Process. 2017, 114, 5566,  DOI: 10.1016/j.cep.2017.01.001
    18. 18
      Di Martino, P.; Conflant, P.; Drache, M.; Huvenne, J. P.; Guyot-Hermann, A. M. Preparation and physical characterization of forms II and III of paracetamol. J. Therm. Anal. Calorim. 1997, 48, 447458,  DOI: 10.1007/BF01979491
    19. 19
      Wang, I. C.; Lee, M. J.; Seo, D. Y.; Lee, H. E.; Choi, Y.; Kim, W. S.; Kim, C. S.; Jeong, M. Y.; Choi, G. J. Polymorph transformation in paracetamol monitored by in-line NIR spectroscopy during a cooling crystallization process. AAPS PharmSciTech 2011, 12 (2), 764770,  DOI: 10.1208/s12249-011-9642-x
    20. 20
      Jordens, J.; Gielen, B.; Braeken, L.; Van Gerven, T. Determination of the effect of the ultrasonic frequency on the cooling crystallization of paracetamol. Chem. Eng. Process. 2014, 84, 3844,  DOI: 10.1016/j.cep.2014.01.006
    21. 21
      Kaialy, W.; Larhrib, H.; Chikwanha, B.; Shojaee, S.; Nokhodchi, A. An approach to engineer paracetamol crystals by antisolvent crystallization technique in presence of various additives for direct compression. Int. J. Pharm. 2014, 464 (1–2), 5364,  DOI: 10.1016/j.ijpharm.2014.01.026
    22. 22
      Sibik, J.; Sargent, M. J.; Franklin, M.; Zeitler, J. A. Crystallization and phase changes in paracetamol from the amorphous solid to the liquid phase. Mol. Pharmaceutics 2014, 11 (4), 13261334,  DOI: 10.1021/mp400768m
    23. 23
      Wang, I.-C.; Lee, M.-J.; Seo, D.-Y.; Lee, H.-E.; Choi, Y.; Kim, W.-S.; Kim, C.-S.; Jeong, M.-Y.; Choi, G. J. Polymorph transformation in paracetamol monitored by in-line NIR spectroscopy during a cooling crystallization process. AAPS PharmSciTech 2011, 12, 764770,  DOI: 10.1208/s12249-011-9642-x
    24. 24
      Madane, K.; Ranade, V. V. Anti-solvent crystallization: Particle size distribution with different devices. Chem. Eng. J. 2022, 446, 137235,  DOI: 10.1016/j.cej.2022.137235
    25. 25
      Chew, C. M.; Ristic, R. I.; Dennehy, R. D.; De Yoreo, J. J. Crystallization of paracetamol under oscillatory flow mixing conditions. Cryst. Growth Des. 2004, 4 (5), 10451052,  DOI: 10.1021/cg049913l
    26. 26
      Keshavarz, L.; Pishnamazi, M.; Khandavilli, U. B. R.; Shirazian, S.; Collins, M. N.; Walker, G. M.; Frawley, P. J. Tailoring crystal size distributions for product performance, compaction of paracetamol. Arabian J. Chem. 2021, 14 (4), 103089,  DOI: 10.1016/j.arabjc.2021.103089
    27. 27
      Sauerbrey, G. Verwendung von Schwingquarzen zur Wägung dünner Schichten und zur Mikrowägung. Z. Phys. 1959, 155 (2), 206222,  DOI: 10.1007/BF01337937
    28. 28
      Janshoff, A.; Galla, H. J.; Steinem, C. Piezoelectric mass-sensing devices as biosensors-an alternative to optical biosensors?. Angew. Chem., Int. Ed. 2000, 39 (22), 40044032,  DOI: 10.1002/1521-3773(20001117)39:22<4004::AID-ANIE4004>3.0.CO;2-2
    29. 29
      Xiang, C.; Xie, Q.; Hu, J.; Yao, S. Studies on electrochemical copolymerization of aniline with o-phenylenediamine and degradation of the resultant copolymers via electrochemical quartz crystal microbalance and scanning electrochemical microscope. Synth. Met. 2006, 156 (5–6), 444453,  DOI: 10.1016/j.synthmet.2006.01.010
    30. 30
      Snook, G. A.; Chen, G. Z. The measurement of specific capacitances of conducting polymers using the quartz crystal microbalance. J. Electroanal. Chem. 2008, 612 (1), 140146,  DOI: 10.1016/j.jelechem.2007.08.024
    31. 31
      Madhumitha, D.; Dhathathreyan, A. Interaction of Myoglobin colloids with BSA in solution: Insights into complex formation and elastic compliance. Int. J. Biol. Macromol. 2017, 105, 12591268,  DOI: 10.1016/j.ijbiomac.2017.07.157
    32. 32
      Dhanasekaran, M.; Jaganathan, M.; Dhathathreyan, A. Colloids versus solution state adsorption of proteins: Interaction of Myoglobin with supported lipid bilayers. Int. J. Biol. Macromol. 2018, 114, 434440,  DOI: 10.1016/j.ijbiomac.2018.03.078
    33. 33
      Liu, L.-S.; Kim, J.-M.; Kim, W.-S. Quartz Crystal Microbalance Technique for in Situ Analysis of Supersaturation in Cooling Crystallization. Anal. Chem. 2016, 88 (11), 57185724,  DOI: 10.1021/acs.analchem.5b04609
    34. 34
      Sarvothaman, V. P.; Velisoju, V. K.; Subburaj, J.; Panithasan, M. S.; Kulkarni, S. R.; Castaño, P.; Turner, J.; Guida, P.; Roberts, W. L.; Nagarajan, S. Is cavitation a truly sensible choice for intensifying photocatalytic oxidation processes?–Implications on phenol degradation using ZnO photocatalysts. Ultrason. Sonochem. 2023, 99, 106548,  DOI: 10.1016/j.ultsonch.2023.106548
    35. 35
      Sarvothaman, V. P.; Simpson, A. T.; Ranade, V. V. Modelling of vortex based hydrodynamic cavitation reactors. Chem. Eng. J. 2019, 377, 119639,  DOI: 10.1016/j.cej.2018.08.025
    36. 36
      Ranade, V. V.; Prasad Sarvothaman, V.; Simpson, A.; Nagarajan, S. Scale-up of vortex based hydrodynamic cavitation devices: A case of degradation of di-chloro aniline in water. Ultrason. Sonochem. 2021, 70, 105295,  DOI: 10.1016/j.ultsonch.2020.105295
    37. 37
      Simpson, A.; Ranade, V. V. Flow characteristics of vortex based cavitation devices: Computational investigation on influence of operating parameters and scale. AIChE J. 2019, 65 (9), e16675  DOI: 10.1002/aic.16675
    38. 38
      Bučar, D.-K.; Elliott, J. A.; Eddleston, M. D.; Cockcroft, J. K.; Jones, W. Sonocrystallization Yields Monoclinic Paracetamol with Significantly Improved Compaction Behavior. Angew. Chem., Int. Ed. 2015, 54 (1), 249253,  DOI: 10.1002/anie.201408894
    39. 39
      Kim, H. N.; Suslick, K. S. The Effects of Ultrasound on Crystals: Sonocrystallization and Sonofragmentation. Crystals 2018, 8 (7), 280,  DOI: 10.3390/cryst8070280
    40. 40
      Gielen, B.; Claes, T.; Janssens, J.; Jordens, J.; Thomassen, L. C. J.; Gerven, T. V.; Braeken, L. Particle Size Control during Ultrasonic Cooling Crystallization of Paracetamol. Chem. Eng. Technol. 2017, 40, 13001308,  DOI: 10.1002/ceat.201600647
    41. 41
      Kachrimanis, K.; Braun, D. E.; Griesser, U. J. Quantitative analysis of paracetamol polymorphs in powder mixtures by FT-Raman spectroscopy and PLS regression. J. Pharm. Biomed. Anal. 2007, 43 (2), 407412,  DOI: 10.1016/j.jpba.2006.07.032
    42. 42
      Yamamura, S.; Momose, Y. Characterization of monoclinic crystals in tablets by pattern-fitting procedure using X-ray powder diffraction data. Int. J. Pharm. 2003, 259 (1), 2737,  DOI: 10.1016/S0378-5173(03)00206-0
    43. 43
      Shtukenberg, A. G.; Tan, M.; Vogt-Maranto, L.; Chan, E. J.; Xu, W.; Yang, J.; Tuckerman, M. E.; Hu, C. T.; Kahr, B. Melt Crystallization for Paracetamol Polymorphism. Cryst. Growth Des. 2019, 19 (7), 40704080,  DOI: 10.1021/acs.cgd.9b00473
    44. 44
      Oloyede, O. O.; Alabi, Z. O.; Akinyemi, A. O.; Oyelere, S. F.; Oluseye, A. B.; Owoyemi, B. C. D. Comparative evaluation of acetaminophen form (I) in commercialized paracetamol brands. Sci. Afr. 2023, 19, e01537  DOI: 10.1016/j.sciaf.2022.e01537
    45. 45
      Giordano, F.; Rossi, A.; Bettini, R.; Savioli, A.; Gazzaniga, A.; Novák, C. S. Thermal behavior of paracetamol-polymeric excipients mixtures. J. Therm. Anal. Calorim. 2002, 68 (2), 575590,  DOI: 10.1023/A:1016004206043
    46. 46
      Klímová, K.; Leitner, J. DSC study and phase diagrams calculation of binary systems of paracetamol. Thermochim. Acta 2012, 550, 5964,  DOI: 10.1016/j.tca.2012.09.024
    47. 47
      Sacchetti, M. Thermodynamic Analysis of DSC Data for Acetaminophen Polymorphs. J. Therm. Anal. Calorim. 2001, 63, 345350,  DOI: 10.1023/A:1010180123331
    48. 48
      Liu, L.-S.; Kim, J.-M.; Chang, S.-M.; Choi, G.-J.; Kim, W.-S. Quartz Crystal Microbalance Technique for Analysis of Cooling Crystallization. Anal. Chem. 2013, 85, 47904796,  DOI: 10.1021/ac400585c
    49. 49
      Lapidot, T.; Sedransk Campbell, K. L.; Heng, J. Y. Y. Model for Interpreting Surface Crystallization Using Quartz Crystal Microbalance: Theory and Experiments. Anal. Chem. 2016, 88 (9), 48864893,  DOI: 10.1021/acs.analchem.6b00713